Capacity of Human Nisin- and Pediocin-Producing Lactic Acid Bacteria To Reduce Intestinal Colonization by Vancomycin-Resistant Enterococci
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
This study demonstrated the capacity of bacteriocin-producing lactic acid bacteria (LAB) to reduce intestinal colonization by vancomycin-resistant enterococci (VRE) in a mouse model. Lactococcus lactis MM19 and Pediococcus acidilactici MM33 are bacteriocin producers isolated from human feces. The bacteriocin secreted by P. acidilactici is identical to pediocin PA-1/AcH, while PCR analysis demonstrated that L. lactis harbors the nisin Z gene. LAB were acid and bile tolerant when assayed under simulated gastrointestinal conditions. A well diffusion assay using supernatants from LAB demonstrated strong activity against a clinical isolate of VRE. A first in vivo study was done using C57BL/6 mice that received daily intragastric doses of L. lactis MM19, P. acidilactici MM33, P. acidilactici MM33A (a pediocin mutant that had lost its ability to produce pediocin), or phosphate-buffered saline (PBS) for 18 days. This study showed that L. lactis and P. acidilactici MM33A increased the concentrations of total LAB and anaerobes while P. acidilactici MM33 decreased the Enterobacteriaceae populations. A second in vivo study was done using VRE-colonized mice that received the same inocula as those in the previous study for 16 days. In L. lactis -fed mice, fecal VRE levels 1.73 and 2.50 log 10 CFU/g lower than those in the PBS group were observed at 1 and 3 days postinfection. In the P. acidilactici MM33-fed mice, no reduction was observed at 1 day postinfection but a reduction of 1.85 log 10 CFU/g was measured at 3 days postinfection. Levels of VRE in both groups of mice treated with bacteriocin-producing LAB were undetectable at 6 days postinfection. No significant difference in mice fed the pediocin-negative strain compared to the control group was observed. This is the first demonstration that human L. lactis and P. acidilactici nisin- and pediocin-producing strains can reduce VRE intestinal colonization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028 · cited 3×
“The problem is that enterococci can be considered to be an important reservoir of resistance genes and this glycopeptide resistance can be transferred to more-pathogenic bacteria, such as staphylococci and streptococci (4, 6, 30).”
BackgroundCorr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C., & Gahan, C. G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700440104 · Cited by 853
Enterococcal infections: host response, therapeutic, and prophylactic possibilities
Koch, S., Hufnagel, M., Theilacker, C., & Huebner, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.027 · Cited by 159
Cited by
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Impact of antibiotics on the human microbiome and consequences for host health
Patangia, D. V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., & Stanton, C. (2022) · MicrobiologyOpen · doi:10.1002/mbo3.1260 · Cited by 754
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Kim, S., Covington, A., & Pamer, E. G. (2017) · Immunological Reviews · doi:10.1111/imr.12563 · Cited by 741
Antibacterial activities of bacteriocins: application in foods and pharmaceuticals
Yang, S.-C., Lin, C.-H., Sung, C. T., & Fang, J.-Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00241 · Cited by 726
Bacteriocin Production: a Probiotic Trait?
Dobson, A., Cotter, P. D., Ross, R. P., & Hill, C. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05576-11 · Cited by 687
Biomedical applications of nisin
Shin, J. M., Gwak, J. W., Kamarajan, P., Fenno, J. C., Rickard, A. H., & Kapila, Y. L. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13033 · Cited by 607
“lactis strain was shown to reduce the intestinal colonization of VRE in a mouse infection model (Millette et al. 2008).”
InfluentialInteraction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review
Duda-Chodak, A., Tarko, T., Satora, P., & Sroka, P. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0852-y · Cited by 599
Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations
Soltani, S., Hammami, R., Cotter, P. D., Rebuffat, S., Said, L. B., Gaudreau, H., Bédard, F., Biron, E., Drider, D., & Fliss, I. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa039 · Cited by 544
Stecher, B., Chaffron, S., Käppeli, R., Hapfelmeier, S., Freedrich, S., Weber, T. C., Kirundi, J., Suar, M., McCoy, K. D., von Mering, C., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000711 · Cited by 435
Discovery of antimicrobial peptides in the global microbiome with machine learning
Santos-Júnior, C. D., Torres, M. D. T., Duan, Y., Rodríguez del Río, Á., Schmidt, T. S. B., Chong, H., Fullam, A., Kuhn, M., Zhu, C., Houseman, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.013 · Cited by 419
Hassan, M., Kjos, M., Nes, I. F., Diep, D. B., & Lotfipour, F. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05338.x · Cited by 402
“Millette et al. (2008) also reported that bacteriocin-producing Pediococcus acidilactici (pediocin PA-1 producer) and L. lactis (nisin Z producer) could reduce colonization of vancomycin-resistant enterococci (VRE) in the intestine of mice.”
Backgroundvan Zyl, W. F., Deane, S. M., & Dicks, L. M. T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1831339 · Cited by 340
Regulation of Bacterial Pathogenesis by Intestinal Short-Chain Fatty Acids
Sun, Y., & O’Riordan, M. X. D. (2013) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-407672-3.00003-4 · Cited by 338
Gómez, N. C., Ramiro, J. M. P., Quecan, B. X. V., & de Melo Franco, B. D. G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00863 · Cited by 319
Microbiome therapeutics — Advances and challenges
Mimee, M., Citorik, R. J., & Lu, T. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.032 · Cited by 317
O'Shea, E. F., Cotter, P. D., Stanton, C., Ross, R. P., & Hill, C. (2012) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.05.025 · Cited by 305
“This benefit was attributed to the minimal impact of the bacteriocin on the commensal gut flora, (Millette et al., 2008), again highlighting the advantage and efficacy of bacteriocins over broad spectrum antibiotics.”
BackgroundInfluentialBacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
Anjana, & Tiwari, S. K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.851140 · Cited by 264
Review: The use of direct fed microbials to mitigate pathogens and enhance production in cattle
McAllister, T. A., Beauchemin, K. A., Alazzeh, A. Y., Baah, J., Teather, R. M., & Stanford, K. (2011) · Canadian Journal of Animal Science · doi:10.4141/cjas10047 · Cited by 251
Bacteriocins: Recent trends and potential applications
Bali, V., Panesar, P. S., Bera, M. B., & Kennedy, J. F. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.729231 · Cited by 119
“Nisin- and pediocinproducing lactic acid bacteria have been shown to reduce intestinal colonization of pathogenic enterococci (Millette et al., 2008).”
Background
Metadata
- Authors
- Millette, M., Cornut, G., Dupont, C., Shareck, F., Archambault, D., & Lacroix, M.
- Venue
- Applied and Environmental Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2008-04
- Volume
- 74
- Issue
- 7
- Pages
- 1997-2003
- ISSN
- 0099-2240 (ISSN-L)
- 1098-5336
- OpenAlex
- W1992775178
- Cited by
- 153
- References
- 3
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.